Figure 6. Total consumption (DDD/1,000 inhabitant-days) by quarter of oral fluoroquinolones (J01MA) dispensed by retail pharmacies in Canada, 2000–2009
| Quarter and Year |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
| Antimicrobial |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
| Ofloxacin (J01MA01) |
0.14 |
0.14 |
0.12 |
0.13 |
0.13 |
0.11 |
0.10 |
0.11 |
0.10 |
0.09 |
0.08 |
0.09 |
0.09 |
0.08 |
0.08 |
0.08 |
0.08 |
0.07 |
0.07 |
0.07 |
0.06 |
0.06 |
0.05 |
0.06 |
0.06 |
0.06 |
0.05 |
0.06 |
0.06 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.04 |
0.04 |
0.04 |
0.04 |
0.04 |
0.04 |
| Ciprofloxacin (J01MA02) |
1.16 |
1.10 |
1.09 |
1.19 |
1.19 |
0.97 |
0.97 |
1.11 |
1.02 |
0.99 |
1.03 |
1.10 |
1.07 |
1.02 |
1.07 |
1.10 |
1.09 |
1.05 |
1.09 |
1.09 |
1.13 |
1.06 |
1.08 |
1.14 |
1.17 |
1.12 |
1.15 |
1.21 |
1.24 |
1.16 |
1.19 |
1.23 |
1.25 |
1.17 |
1.18 |
1.23 |
1.26 |
1.15 |
1.20 |
1.21 |
| Norfloxacin (J01MA06) |
0.28 |
0.28 |
0.29 |
0.27 |
0.26 |
0.28 |
0.28 |
0.28 |
0.25 |
0.25 |
0.27 |
0.26 |
0.24 |
0.24 |
0.25 |
0.24 |
0.22 |
0.22 |
0.23 |
0.22 |
0.20 |
0.20 |
0.21 |
0.20 |
0.19 |
0.19 |
0.19 |
0.19 |
0.17 |
0.17 |
0.17 |
0.16 |
0.15 |
0.15 |
0.16 |
0.15 |
0.14 |
0.14 |
0.15 |
0.13 |
| Levofloxacin (J01MA12) |
0.25 |
0.23 |
0.22 |
0.36 |
0.46 |
0.34 |
0.25 |
0.38 |
0.42 |
0.30 |
0.24 |
0.34 |
0.36 |
0.30 |
0.25 |
0.38 |
0.39 |
0.31 |
0.25 |
0.34 |
0.38 |
0.28 |
0.21 |
0.27 |
0.31 |
0.24 |
0.20 |
0.28 |
0.32 |
0.23 |
0.18 |
0.25 |
0.29 |
0.24 |
0.18 |
0.26 |
0.28 |
0.22 |
0.17 |
0.25 |
| Moxifloxacin (J01MA14) |
|
|
|
0.03 |
0.08 |
0.11 |
0.08 |
0.16 |
0.20 |
0.18 |
0.13 |
0.23 |
0.28 |
0.24 |
0.17 |
0.28 |
0.33 |
0.26 |
0.17 |
0.29 |
0.43 |
0.30 |
0.20 |
0.33 |
0.43 |
0.35 |
0.27 |
0.48 |
0.59 |
0.41 |
0.28 |
0.43 |
0.54 |
0.42 |
0.29 |
0.44 |
0.54 |
0.41 |
0.28 |
0.48 |
Return to the previous link